FdaApplication
ANDA 212047
Identifiers
- fda_app_no: ANDA212047
Properties
| Property | Value |
|---|---|
| applicant_name | SOMERSET THERAPEUTICS LLC |
| application_type | ANDA |
| approval_date | 2023-01-27 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CHLORZOXAZONE | CHLORZOXAZONE | 375MG | TABLET;ORAL |
| CHLORZOXAZONE | CHLORZOXAZONE | 750MG | TABLET;ORAL |
2 products